Clinically, our data indicate that GLP-1 receptor agonists may be a valuable supplementary therapy for some infertile individuals with obesity and PCOS, especially when metabolic abnormalities are implicated in reproductive failure. The gene discussed is GLP1R; the disease is Infertility.